System Transmission

Top Signal

100#1 JOB

Activity

2179Ripe

+938 today

System

Livenow

Terminal Asset View

stockNASDAQ

NTRP

$2.92-1.02%

Neurotrope Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

40Neutral

Live Analysis Active

Company Mission

Neurotrope Inc creates experimental drugs designed to treat Alzheimer's disease, targeting memory loss and cognitive issues. Doctors and patients use these drugs in clinical trials to test their effectiveness and safety. The company makes money by advancing these drugs through trials, seeking FDA approval, and potentially licensing or selling them to larger pharmaceutical companies.

NTR

Industry Context

This company operates in the biotechnology sector, focusing on neurological disorders like Alzheimer's disease. It competes with larger pharmaceutical firms by developing novel treatments through clinical trials. The industry is highly regulated, requiring FDA approvals for drug commercialization. Success depends on trial outcomes and market adoption of new therapies.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

83Matrix

Market Momentum

46.3— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

-1.02%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing NTRP across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:48 AM UTC

As-of As of 2026-03-16T06:33:17.048Z UTC (~15m delay).

Develops drugs for Alzheimer's disease, aiming to slow cognitive decline in patients through clinical trials and potential future sales.

Weekly chart shows range contraction near $0, indicating a coiling pattern that often precedes breakouts. Watch for price breaking above this level.

No technical indicators available, but monitor if price holds above $0, signaling stability in a volatile biotech sector. Watch for sector recovery.

Industry trend toward Alzheimer's research is driving interest, with price testing $0 resistance, signaling potential growth. Watch for clinical trial updates.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...